Although Tesofensine is not yet available on the market, it offers a glimpse into the future of the weight loss industry
Securing insurance approval typically requires: Thorough documentation of SFN diagnosis with objective testing Evidence of failure with conventional treatments Documentation of suspected immune-mediated mechanisms Letters of medical necessity detailing the rationale and expected benefits Sometimes peer-to-peer reviews between the prescribing physician and insurance medical directors In my practice, I've found that patients with documented autoimmune comorbidities or specific autoantibodies generally have better success with insurance approval than those with idiopathic SFN, even when symptoms and presentation are otherwise similar
Effects of astaxanthin on oxidative stress in overweight and obese adults
Crucially, in an LPS-induced mouse model of acute lung injury, treatment with compound 25L significantly alleviated pulmonary inflammatory infiltration and levels of pro-inflammatory cytokines (IL-1, IL-6, TNF-), providing direct pharmacological evidence supporting the hypothesis that P2Y14R inhibition alleviates lung inflammation (Ma et al., 2025)
Yes, for many people it is
